[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-368068-105":59,"doc-detail-368068-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","dynamic-and-extensive-a-to-i-rna-recoding-in-immunoglobulin-shapes-myeloid-neoplasm-transcriptome","Dynamic and extensive A-to-I RNA recoding in immunoglobulin shapes myeloid neoplasm transcriptome","","Dynamic A-to-I RNA recoding in human myeloid neoplasms remains insufficiently characterized despite links between editing sites and cancer. By comparing transcriptomes from healthy controls, low-risk myelodysplastic syndrome, high-risk myelodysplastic syndrome, and acute myeloid leukemia, the study identifies widespread, disease-progressive and dynamically regulated RNA editing events. Immunoglobulin genes show enrichment of nonsynonymous editing with markedly altered editing levels, including recoding patterns associated with genomic substitutions fixed as G during mammalian evolution.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/dynamic-and-extensive-a-to-i-rna-recoding-in-immunoglobulin-shapes-myeloid-neoplasm-transcriptome/368068/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/dynamic-and-extensive-a-to-i-rna-recoding-in-immunoglobulin-shapes-myeloid-neoplasm-transcriptome/368068.png","ImageObject",300,407,{"name":92,"@type":93},"CatatanPagi","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-31","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What problem does the study address about A-to-I RNA editing in myeloid neoplasms?","Question",{"text":112,"@type":113},"The study addresses that dynamic RNA editing during myeloid neoplasm progression is less known, limiting understanding of the functional repertoire of RNA editing in blood diseases.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was RNA editing analyzed in different disease stages?",{"text":117,"@type":113},"Transcriptomes from healthy controls, low-risk myelodysplastic syndrome, high-risk myelodysplastic syndrome, and acute myeloid leukemia were analyzed to reveal widespread and dynamic editing events across progression.",{"name":119,"@type":110,"acceptedAnswer":120},"What is notable about immunoglobulin genes in this study?",{"text":121,"@type":113},"Immunoglobulin genes are enriched for nonsynonymous editing sites with significantly altered editing levels in myeloid neoplasms, and many recoding sites show genomic substitutions linked to G fixed during mammalian evolution.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},368068,1790731662,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":44,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},962090894170,"https://ap-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","RESEARCH ARTICLE  \nDynamic and extensive A-to-I RNA recoding in  \nimmunoglobulin shapes myeloid neoplasm transcriptome  \nReceived for publication, October 16, 2025, and in revised form, December 1, 2025 Published, Papers in Press, December 17, 2025 [https://doi.org/10.1016/j.jbc.2025.1](https://doi.org/10.1016/j.jbc.2025.1)11066  \nQi Cao1,‡, Yuqing Wang2,3,‡, and Yuange Duan4, *  \nFrom the 1International Cancer Institute, Health Science Center, Peking University, Beijing, China; 2Beijing Jishuitan Hospital, Capital Medical University, Beijing, China; 3Department of Laboratory Medicine, Beijing Jishuitan Hospital, Peking University Fourth School of Clinical Medicine, Beijing, China; 4State Key Laboratory of Agricultural and Forestry Biosecurity, MOA Key Lab of Pest Monitoring and Green Management, Department of Entomology, College of Plant Protection, China Agricultural University, Beijing, China  \nReviewed by members of the JBC Editorial Board. Edited by Brian D. Strahl  \nFunctional adenosine-to-inosine mRNA editing sites are continuously identified in cellular organisms. Despite that several editing sites have been linked to various human cancers, the dynamic RNA editing in the progression of myeloid neoplasms remains less known, preventing a clearer understanding of the functional repertoire of RNA editing in blood diseases. By analyzing transcriptomes from healthy controls, low-risk myelodysplastic syndrome, high-risk myelodysplastic syndrome, and acute myeloid leukemia, we reveal widespread and dynamic RNA editing events accompanying disease progression. Immunoglobulin genes are enriched for nonsynonymous editing sites with significantly altered editing levels in myeloid neoplasms, and such recoding sites often show genomic substitutions to hardwired G during mammalian evolution. Collectively, our findings broaden the functional spectrum of RNA editing in human and highlight its potential as a driver, responsor, or biomarker of myeloid neoplasms, underscoring its significance in human disease evolution.  \nAdenosine-to-inosine (A-to-I) RNA editing, mediated by ADAR (adenosine deaminase acting on RNA) (1), is one of the most prevalent RNA modifications in the transcriptomes (2–4). Due to the structural similarity between I and G, A-to-I editing introduces A-to-G variations in mRNAs without changing the genome sequence (5, 6). Attention has been paid to the recoding sites in coding sequence (CDS), namely thenonsynonymous editing events. Functional recoding sites in cephalopods (7, 8), insects (9–11), and fungi (12, 13) have been continuously discovered. In mammals, while several functionally essential recoding sites were discovered, such asthe glutamate receptor GRIA2 Q > R site (14–16) and multiple clustered recoding sites in serotonin 2C receptor HTR2C (17), a more widely studied function of mammalian RNA editing is the “immune protector” role (5, 18, 19), where the extensive editing in repetitive sequences prevent MDA5 from  \n‡ Co-first author.  \n* For correspondence: Yuange Duan, [duanyuange@cau.edu.cn](duanyuange@cau.edu.cn).  \nsensing endogenous dsRNA as nonself (20). Studies on the distinct functions of coding and noncoding RNA editing sites might benefit from the unique “division of labor” of mammalian ADARs, where ADAR1 mainly targets noncoding and repeat regions, ADAR2 prefers exons and coding regions, and ADAR3 is catalytically inactive (21). In humans, with tens of millions of potentially editable adenosines in the transcriptome (22), the functional relevance of many editing sites remains to be determined. To narrow down functional editing sites, researchers turned to explore the roles of RNA editing in several human diseases, including cancers (23, 24). A number of candidate sites have been identified within noncoding regions but are rarer in coding regions (25, 26). Furthermore, while RNA editing has been extensively studied in solid tumors (23, 24), its role in hematological diseases such as myeloid neoplasms r","cbCaimCrp0ZDHcD2","https://ap.wps.com/l/cbCaimCrp0ZDHcD2","pdf",5225985,"English","# Introduction\n## Background on A-to-I RNA editing\n## Prior knowledge in myeloid neoplasms\n# Study Rationale and Knowledge Gaps\n## Limited transcriptome-wide coding editing evidence\n## Need for progressive datasets","[{\"question\":\"What problem does the study address about A-to-I RNA editing in myeloid neoplasms?\",\"answer\":\"The study addresses that dynamic RNA editing during myeloid neoplasm progression is less known, limiting understanding of the functional repertoire of RNA editing in blood diseases.\"},{\"question\":\"How was RNA editing analyzed in different disease stages?\",\"answer\":\"Transcriptomes from healthy controls, low-risk myelodysplastic syndrome, high-risk myelodysplastic syndrome, and acute myeloid leukemia were analyzed to reveal widespread and dynamic editing events across progression.\"},{\"question\":\"What is notable about immunoglobulin genes in this study?\",\"answer\":\"Immunoglobulin genes are enriched for nonsynonymous editing sites with significantly altered editing levels in myeloid neoplasms, and many recoding sites show genomic substitutions linked to G fixed during mammalian evolution.\"}]","Dynamic and extensive A-to-I RNA recoding in immunoglobulin shapes myeloid neoplasm transcriptome | PDF",1790174817,23,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7f6042b6233af476ddf1cbc41ab3a11f.webp",983,1296,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a4ec0b8fa2404a23c009d1077ed3b1ea.webp",982,1294,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3e53b92294ad528f660d88bad2d8b0fb.webp",981,1293,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2160d70b4de4fbc6f33f5bc458860fde.webp",980,1292]